Novavax Soars 80% After COVID-19 Vaccine Funding and Earnings


Novavax wins US contract for coronavirus COVID-19 vaccine from US Department of Defense

US Department of Defense Contract for COVID-19 Vaccine, $60 million funding for manufacturing of NVX-CoV2373
10 million doses to be delivered to DoD in 2020

NVAX has said it aims to produce 100 million doses by the end of the year
Novavax began clinical trials of its coronavirus vaccine candidate in Australia in May.
Initial results from those trials are expected in July.